SCHEMBL1699198

SCHEMBL1699198

Cc1ccc(-c2ccc(OCc3ccccc3)cc2)nc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 2/20 0.60
ENPP3 O14638 1/20 0.57
ENPP1 P22413 1/20 0.57
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MEN1 O00255 1/20 0.54
NPC1 O15118 1/20 0.54
POLB P06746 1/20 0.54
KMT2A Q03164 1/20 0.54
IKBKE Q14164 1/20 0.49
GSTP1 P09211 1/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
PTGS1 P23219 1/20 0.49
SLC6A2 P23975 1/20 0.49
CYP2C19 P33261 1/20 0.49
PTGS2 P35354 1/20 0.49
SLC6A3 Q01959 1/20 0.49
HIF1A Q16665 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128671 0.82 LMNA (0.60) ENPP3ENPP1RAB9ASMN1; SMN2IKBKE
SCHEMBL8612081 0.82 DGAT1 (0.56) DGAT1ENPP3ENPP1RAB9ASMN1; SMN2
SCHEMBL8615555 0.82 DGAT1 (0.56) DGAT1ENPP3ENPP1RAB9ASMN1; SMN2
SCHEMBL9048918 0.80 CYP1A2 (0.64) DGAT1ENPP3ENPP1RAB9ASMN1; SMN2
SCHEMBL128703 0.80 LMNA (0.67) RAB9ASMN1; SMN2LMNACYP1A2PTGS1
SCHEMBL1765500 0.78 DGAT1 (0.53) DGAT1ENPP3ENPP1RAB9ASMN1; SMN2
SCHEMBL9084030 0.78 DGAT1 (0.53) DGAT1ENPP3ENPP1RAB9ASMN1; SMN2
SCHEMBL12359222 0.78 CYP3A4 (0.61) RAB9AMEN1NPC1KMT2AHDAC6
SCHEMBL404433 0.78 CYP3A4 (0.66) RAB9ASMN1; SMN2MEN1NPC1KMT2A
SCHEMBL27743534 0.78 CYP1A2 (0.61) DGAT1ENPP3ENPP1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011163355-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-29 WO disclosed